Nyrada Inc.

ASX (AUD): Nyrada Inc. (NYR)

Last Price

0.096

Today's Change

-0.002 (2.04%)

Day's Change

0.096 - 0.098

Trading Volume

321,445

Overview

Market Cap

14 Million

Shares Outstanding

156 Million

Avg Volume

4,846,318

Avg Price (50 Days)

0.09

Avg Price (200 Days)

0.04

PE Ratio

-3.20

EPS

-0.03

Earnings Announcement

20-Feb-2024

Previous Close

0.10

Open

0.10

Day's Range

0.096 - 0.098

Year Range

0.018 - 0.17

Trading Volume

321,445

Price Change Highlight

1 Day Change

-2.04%

5 Day Change

-3.03%

1 Month Change

-8.57%

3 Month Change

317.39%

6 Month Change

357.14%

Ytd Change

336.36%

1 Year Change

1.05%

3 Year Change

-69.03%

5 Year Change

-59.15%

10 Year Change

-59.15%

Max Change

-59.15%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular, neurodegenerative, and chronic inflammatory diseases. Its products in the drug development stage include PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs; a neuroprotectant drug to reduce the disability in patients with ischaemic stroke and traumatic brain injury; a drug to treat pain associated with peripheral nerve damage; and a drug to treat autoimmune diseases, such as psoriasis. The company has collaboration with Walter Reed Army Institute of Research and University of New South Wales, Sydney. Nyrada Inc. was incorporated in 2017 and is based in Gordon, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment